Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-137.08%
↑ 96% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-3630.03%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -137.08% | +36.0% |
| 2024 | -214.34% | +99.4% |
| 2023 | -35948.86% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |